Furlanetto, J., Möbus, V., Schneeweiss, A., Rhiem, K., Tesch, H., Blohmer, J., . . . Fasching, P. A. (2021). Germline BRCA1/2 mutations and severe haematological toxicities in patients with breast cancer treated with neoadjuvant chemotherapy. European journal of cancer, 145, . https://doi.org/10.1016/j.ejca.2020.12.007
Chicago-Zitierstil (17. Ausg.)Furlanetto, Jenny, et al. "Germline BRCA1/2 Mutations and Severe Haematological Toxicities in Patients with Breast Cancer Treated with Neoadjuvant Chemotherapy." European Journal of Cancer 145 (2021). https://doi.org/10.1016/j.ejca.2020.12.007.
MLA-Zitierstil (9. Ausg.)Furlanetto, Jenny, et al. "Germline BRCA1/2 Mutations and Severe Haematological Toxicities in Patients with Breast Cancer Treated with Neoadjuvant Chemotherapy." European Journal of Cancer, vol. 145, 2021, https://doi.org/10.1016/j.ejca.2020.12.007.